Business ❯Pharmaceuticals

Drug Development

Clinical Trials Weight Loss Drugs Market Trends Research and Development Obesity Drugs Obesity Treatments Weight Loss Medications FDA Approval Obesity Medications Oncology Market Access Market Demand Market Competition Market Introduction Alzheimer's Treatment Product Liability Legal Issues Clinical Research Market Performance Keytruda Market Analysis Market Launch GLP-1 Medications Cambrex Market Approval Rare Disease Drugs Market Accessibility Cancer Medications Lawsuits Weight-Loss Drugs Cost-Effectiveness Rare Disease Treatments Novo Nordisk Obesity Treatment Pain Management Revenue Projections Cost Management Cancer Treatments Anti-Diabetic Drugs Roivant Sciences Weight-loss Drugs Neuroscience Cerevel MZE001 KarXT Bristol Myers Squibb CRISPR-Cas9 Regulatory Approval GLP-1 Weight Loss Drugs Weight Loss Intellectual Property Alzheimer's Epilepsy Treatment GLP-1 Weight-Loss Drug User Fee Programs Obesity Drug Partnerships Financial Analysis Weight-Loss Pill Oncology Treatments COVID-19 Vaccines Vaccine Development Opioid Use Disorder Vaccine Production Smoking Cessation Opioid Treatment Obesity and Diabetes Drugs Manufacturing Covid-19 Vaccines Biologics

Bayer Signals Potential End to US Glyphosate Sales as Legal Pressures Mount

Facing 67,000 unresolved lawsuits and $11 billion in settlements, Bayer proposes a 35% capital increase and accelerates restructuring efforts.

Novo Nordisk Seeks FDA Approval as Eli Lilly's Weight-Loss Pill Advances

Pfizer Halts Development of Oral Weight-Loss Pill After Liver Injury

Pfizer Halts Development of Danuglipron After Liver Safety Concerns

Novo Nordisk Faces Investor Turmoil as Wegovy Sales and Market Share Decline

Federal Investigation Examines Claims of Pfizer Vaccine Announcement Delay in 2020

Eli Lilly's Mounjaro Launches in India, Targeting Obesity and Diabetes

NHS Approves First Daily Pill for Endometriosis Treatment

Roche and Zealand Partner in $5.3 Billion Deal for Obesity Drug Development

Novo Nordisk's CagriSema Falls Short in Latest Weight-Loss Trial for Diabetes Patients

Biontech Reports €700 Million Loss and Plans Workforce Restructuring

AbbVie Enters Obesity Drug Market with $2.2 Billion Licensing Deal

FDA to Decide on First Twice-Yearly HIV Prevention Shot by June

Novo Nordisk Reports Doubling Wegovy Sales, Projects Slower Growth in 2025

Bristol Myers Squibb Predicts 2025 Revenue Decline, Expands Cost-Cutting Measures

Merck Cuts 2025 Revenue Forecast After Halting Gardasil Shipments to China

UK Tightens Rules for Online Prescriptions of Weight-Loss Drugs

Novo Nordisk's Amycretin Shows 22% Weight Loss in Trial, Boosting Stock

AI-Designed Proteins Show Promise in Neutralizing Snake Venom Toxins

Eli Lilly Lowers 2024 Revenue Forecast Due to Slower Weight-Loss Drug Growth

Elon Musk Promotes Weight-Loss Drug Mounjaro in Viral 'Ozempic Santa' Post

FDA Approves Zepbound as First Medication for Obstructive Sleep Apnea in Adults with Obesity

Novo Nordisk Shares Plunge After Weight-Loss Drug Trial Falls Short

Merck Secures $2 Billion Deal for Experimental Oral Weight Loss Drug from Hansoh Pharma

Elon Musk and RFK Jr. Clash Over Weight-Loss Drug Policies

Alberta Signs $162M Deal to Expand Access to Rare Disease Drugs

Novo Nordisk Launches Wegovy in China at Lower Price Point

AbbVie Stock Plummets After Schizophrenia Drug Trials Fail

Merck's Q3 Earnings Exceed Expectations Despite Gardasil Sales Slump in China

FDA Approves Vyalev for Advanced Parkinson's Disease Treatment

GSK Agrees to $2.2 Billion Settlement Over Zantac Cancer Claims

Rwanda Battles Deadly Marburg Virus Outbreak

U.S. Obesity Rates Decline as Weight-Loss Drugs Gain Popularity

Eli Lilly to Invest $4.5 Billion in New Indiana Drug Manufacturing Facility

Roche Accelerates Obesity Drug Development, Projects $3.6 Billion in Annual Sales

Eli Lilly Invests $1.8 Billion to Expand Drug Production in Ireland

Moderna to Cut $1.1 Billion in R&D Spending as Vaccine Sales Decline

FDA Expands Recall of Diamond Shruumz Mushroom Chocolates

GSK Raises 2024 Targets Amid Strong Cancer and HIV Treatment Sales

Weight-Loss Drug Market Heats Up as Prices Drop and New Treatments Emerge

FDA Delays Approval of Eli Lilly's Alzheimer's Drug Donanemab

FDA Approves Vertex/CRISPR Gene Therapy for Beta Thalassemia

Bristol Myers Squibb Acquires RayzeBio for $4.1 Billion

Bristol Myers Squibb Acquires Karuna Therapeutics in $14 Billion Deal

Sanofi Terminates Licensing Agreement for Pompe Disease Drug Amid FTC Antitrust Lawsuit

AbbVie Acquires Cerevel Therapeutics for $8.7 Billion

AbbVie Acquires Neuroscience Biotech Cerevel for $8.7 Billion

Roche to Acquire Carmot Therapeutics in $2.7 Billion Deal

GSK Acquires Bellus Health for $2 billion, Gaining Control of Experimental Cough Medicine